{"id":15432,"date":"2015-04-21T12:48:26","date_gmt":"2015-04-21T12:48:26","guid":{"rendered":"https:\/\/www.sisinternational.com\/?page_id=15432"},"modified":"2026-05-05T16:28:03","modified_gmt":"2026-05-05T20:28:03","slug":"diagnostic-imaging-market-research","status":"publish","type":"page","link":"https:\/\/www.sisinternational.com\/pl\/ekspertyza\/diagnostic-imaging-market-research\/","title":{"rendered":"Diagnostic Imaging Market Research | SIS International"},"content":{"rendered":"
\n

Badania rynku diagnostyki obrazowej<\/h1>\n
\"SIS<\/figure>\n<\/p>\n

The medical and diagnostic imaging industry is poised to see continued growth in the years ahead as an aging population will increasingly need these important services. Enhanced access to health insurance for many Americans will also improve access to these services.<\/h2>\n

Diagnostic imaging is a big business worldwide, generating billions in revenue.  Diagnostic Market Research provides insight into market opportunities and positioning. <\/span><\/p>\n

MRI\u2019s, Ultrasounds, E<\/span>lastography, and Thermology are becoming increasingly familiar to patients as these sought-after services provide tangible and beneficial medical results.  SIS Mi\u0119dzynarodowe Badania<\/a> assists companies and new entrants in understanding the markets they are already in, and those they wish to penetrate. <\/span><\/p>\n

We provide cutting-edge data, market insights, competitive intelligence services, and expert analysis<\/a> that provide actionable insight for decision making.<\/span><\/p>\n<\/div>\n

Diagnostic Imaging Market Research: How Leading Manufacturers Win Share<\/h1>\n

Diagnostic imaging market research separates manufacturers building durable share from those competing on specs alone. The category rewards firms that read radiologist workflow, hospital capital budgets, and reimbursement shifts before the curve forms. The opportunity sits in the intelligence layer beneath the technology.<\/p>\n

Capital equipment cycles in MRI, CT, ultrasound, PET, and digital radiography have lengthened. Hospital systems consolidate purchasing through integrated delivery networks. Reimbursement codes shift. Reading volumes migrate to teleradiology platforms. Each of these forces changes how a buying decision is actually made, and most product roadmaps still respond to the previous decade’s evidence.<\/p>\n

What Diagnostic Imaging Market Research Reveals That Spec Sheets Miss<\/h2>\n

The conventional approach benchmarks competitors on slice count, Tesla rating, detector resolution, and list price. The better approach maps the buying committee. A modality purchase at a 600-bed academic medical center involves the chief of radiology, the imaging service line administrator, biomedical engineering, supply chain, the CFO, and increasingly the CIO. Each weights the decision differently.<\/p>\n

Diagnostic imaging market research that ignores this structure produces clean reports and stalled tenders. Research that maps it produces win rates. The shift from departmental purchasing to enterprise capital planning has compressed vendor influence at the radiologist level and elevated total cost of ownership analysis at the executive level. Installed base analytics, service contract economics, and uptime guarantees now decide more deals than image quality demonstrations.<\/p>\n

The Modalities Where Growth Is Concentrated<\/h2>\n

Growth is uneven across the imaging portfolio. Demand patterns reward specific positioning rather than broad coverage.<\/p>\n